The global predictive disease analytics market size is calculated at USD 4.24 billion in 2024, grew to USD 4.97 billion in 2025, and is predicted to hit around USD 20.40 billion by 2034, poised to grow at a CAGR of 17.01% between 2024 and 2034. The North America predictive disease analytics market size accounted for USD 1.95 billion in 2024 and is anticipated to grow at the fastest CAGR of 17.14% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Predictive Disease Analytics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Predictive Disease Analytics Market, by Component, 2024-2034
8.1.1 Software & Services
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Hardware
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Predictive Disease Analytics Market, by Deployment, 2024-2034
9.1.1. On-premises
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Cloud-based
9.1.2.1. Market Revenue and Forecast (2021-2034)
10.1. Predictive Disease Analytics Market, by End Users, 2024-2034
10.1.1. Healthcare Payers
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Healthcare Providers
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Other
10.1.3.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Component (2021-2034)
11.1.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.1.3. Market Revenue and Forecast, by End Users (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Component (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.1.4.3. Market Revenue and Forecast, by End Users (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Component (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.1.5.3. Market Revenue and Forecast, by End Users (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Component (2021-2034)
11.2.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.2.3. Market Revenue and Forecast, by End Users (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Component (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.2.4.3. Market Revenue and Forecast, by End Users (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Component (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.2.5.3. Market Revenue and Forecast, by End Users (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Component (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.2.6.3. Market Revenue and Forecast, by End Users (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Component (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.2.7.3. Market Revenue and Forecast, by End Users (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Component (2021-2034)
11.3.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.3.3. Market Revenue and Forecast, by End Users (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Component (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.3.4.3. Market Revenue and Forecast, by End Users (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Component (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.3.5.3. Market Revenue and Forecast, by End Users (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Component (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.3.6.3. Market Revenue and Forecast, by End Users (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Component (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.3.7.3. Market Revenue and Forecast, by End Users (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Component (2021-2034)
11.4.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.4.3. Market Revenue and Forecast, by End Users (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Component (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.4.4.3. Market Revenue and Forecast, by End Users (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Component (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.4.5.3. Market Revenue and Forecast, by End Users (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Component (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.4.6.3. Market Revenue and Forecast, by End Users (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Component (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.4.7.3. Market Revenue and Forecast, by End Users (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Component (2021-2034)
11.5.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.5.3. Market Revenue and Forecast, by End Users (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Component (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.5.4.3. Market Revenue and Forecast, by End Users (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Component (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Deployment (2021-2034)
11.5.5.3. Market Revenue and Forecast, by End Users (2021-2034)
12.1. IBM Corporation
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. SAS Institute Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Optum, Inc. (a subsidiary of UnitedHealth Group)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cerner Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. McKesson Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Allscripts Healthcare Solutions, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Oracle Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Microsoft Corporation
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Health Catalyst, LLC
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Epic Systems Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample